Sign in

CIK 0001504776

  • Large accelerated filer

Warby Parker Inc.

Sign in to watch
Ticker
WRBY
Exchange
NYSE
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800423634
Phone
+1 646-847-7215
Business address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
Former names
JAND, Inc.
  1. 4 Grant or award Director acquired 790 shares (grant or award)
  2. 4 Grant or award Director acquired 15,793 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale 10% owner sold 5,500,000 shares at $15.66 ($86,130,000)
  5. 4 Planned sale Director sold 7,396 shares at $16.31 ($120,629)
  6. 4 Planned sale Chief Financial Officer sold 109,210 shares at an average $16.61 ($1,813,790)
  7. 4 Planned sale Co-Chief Executive Officer sold 76,582 shares at an average $16.65 ($1,275,122)
  8. 4 Grant or award Director acquired 19,724 shares (grant or award)
  9. 4 Grant or award Director acquired 19,724 shares (grant or award)
  10. 4 Grant or award Director acquired 14,793 shares (grant or award)
  11. 4 Planned sale Co-Chief Executive Officer sold 175,616 shares at an average $16.69 ($2,930,499)
  12. 4 Grant or award Director acquired 14,793 shares (grant or award)
  13. 4 Grant or award Director acquired 14,793 shares (grant or award)
  14. 4 Grant or award Director acquired 14,793 shares (grant or award)
  15. 4 Planned sale Chief Financial Officer sold 85,148 shares at an average $16.63 ($1,416,048)
  16. 4 Planned sale Chief Financial Officer sold 24,225 shares at $11.98 ($290,216)
  17. 4 Planned sale Co-Chief Executive Officer sold 80,376 shares at an average $12.09 ($971,528)
  18. 4 Open-market sale Chief Financial Officer sold 8,708 shares at $11.88 ($103,451)
  19. 4 Planned sale Co-Chief Executive Officer sold 78,311 shares at an average $12.21 ($956,335)
  20. 4 Open-market sale Chief Financial Officer sold 8,963 shares at $12.12 ($108,632)

Page 6 of 13 · 260 filings